Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECEHeVac: Heterologous COVID-19 Vaccination in Argentina
NCT04988048Phase 2Unknown
- Sponsor
- Ministerio de Salud
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Viral Vector Vaccines, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Gam-COVID-Vac, ChAdOx1 nCoV-19, BBIBP-CorV, elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Ministerio de Salud. Status: unknown.
02
Drugs
Gam-COVID-VacChAdOx1 nCoV-19BBIBP-CorVelasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04988048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04988048.